English press releases

Logitech G Introduces the G335 Wired Gaming Headset, a Fresh and Minty New Headset for the Color Collection

New Finish Complements the Beautiful, Lightweight Slim Design LAUSANNE, Switzerland & NEWARK, Calif.–(BUSINESS WIRE)– Logitech G, a brand of Logitech (SIX: LOGN) (NASDAQ: LOGI) and...

Croma-Pharma Announces 9-Country Licensing Agreement with Crescita Therapeutics for Pliaglis®

LEOBENDORF, Austria–(BUSINESS WIRE)– Croma-Pharma GmbH (“Croma”) today announced that it has entered into an exclusive commercialization development license agreement with Crescita Therapeutics (TSX: CTX and...

Vertex Announces National Reimbursement Agreement in France for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) and SYMKEVI® (tezacaftor/ivacaftor) for Eligible Cystic Fibrosis Patients

– With this reimbursement agreement more than 1,500 patients now have access to a CFTR modulator therapy for the first time – LONDON–(BUSINESS WIRE)– Vertex...

OAG’s Flight Info API Now Available in the Microsoft Azure Marketplace

Microsoft Azure customers worldwide now gain access to the Flight Info API to take advantage of the scalability, reliability, and agility of Azure to drive...

Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States

– Upfront and approval payments of up to $15 million – Tiered royalties ranging from mid- to high-teen percentage of net sales – Sol-Gel option...

Empagliflozin reduced the risk of cardiovascular events and hospitalization for heart failure compared to DPP-4 inhibitors in people with type 2 diabetes

– Interim analysis of the EMPRISE real-world evidence study showed that empagliflozin was associated with a reduced risk in all-cause mortality, hospitalization for heart failure...

Elior Group Announces Offering of Senior Unsecured Notes and New Senior Bank Debt

PARIS–(BUSINESS WIRE)– Regulatory News: NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION...

Exelixis and Ipsen Announce Cabozantinib in Combination with an Immune Checkpoint Inhibitor Significantly Improved Progression-Free Survival in Phase 3 COSMIC-312 Pivotal Trial in Patients with Previously Untreated Advanced Liver Cancer

ALAMEDA, Calif. & PARIS–(BUSINESS WIRE)– Regulatory News: Exelixis, Inc. (NASDAQ: EXEL) and Ipsen (Euronext: IPN; ADR: IPSEY) today announced that COSMIC-312, the ongoing phase 3...

Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO®, SYMKEVI® and Additional Indications of ORKAMBI® and KALYDECO® for Eligible Patients With Cystic Fibrosis

– Reimbursement agreement also includes certain future indication extensions across all Vertex CF medicines – – Approximately 1,400 patients will now have access to a...

Abbas Hussain Appointed as New Chief Executive Officer of Vifor Pharma

Abbas Hussain will take over as CEO of the Vifor Pharma Group on 16 August 2021 Succeeding Stefan Schulze, who has decided to step down...

IATA Strengthens Operational Scalability By Switching to Rimini Street for Integrated Support and Application Management Services for its SAP Applications

Commercial airline trade association heavily affected by the pandemic’s economic impact realizes improved productivity from unified support solution; frees up IT resources to focus on...

XPeng Inc. Launches Hong Kong Public Offering

GUANGZHOU, China–(BUSINESS WIRE)– XPeng Inc. (“XPeng” or the “Company”, NYSE: XPEV), a leading Chinese smart electric vehicle (“Smart EV”) company, today announced the launch of...

Gett’s B2B Marketplace Upgrades Sustainability Features for Enterprise Clients

Environmental partnerships and 24-hour EV rides in London enable enterprise clients to track, control and reduce CO2 emissions from business travel. LONDON–(BUSINESS WIRE)– Gett, the...

EQRx and Exscientia Enter Strategic Drug Creation, Development and Commercialization Collaboration to Accelerate the Advancement of New World-Class Medicines

Collaboration combines Exscientia’s leading AI-driven drug discovery capabilities and EQRx’s innovative development and commercialization model to substantially accelerate the delivery of novel medicines to more...

Philip Morris International: New Study Shows Near-Doubling in Counterfeit Cigarettes in the European Union Drives Increase of Total Illicit Consumption in 2020

The share of illicit cigarettes increased by 0.5 percentage points, to 7.8% of total consumption in the EU; PMI calls for continued collaboration between public...